Literature DB >> 17081943

Essure: hysteroscopic sterilization.

Marie Hastings-Tolsma1, Priscilla Nodine, Stephanie B Teal.   

Abstract

Essure, a new female sterilization method approved by the US Food and Drug Administration, offers women a new option for controlling fertility. The technique is done without an incision, is hormone-free, and can be performed on an outpatient basis under local anesthesia. There are few or no side effects. It is important for providers to understand how the device works, appropriate candidates for use, and requirements for preplacement and postplacement management.

Entities:  

Mesh:

Year:  2006        PMID: 17081943     DOI: 10.1016/j.jmwh.2006.04.002

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  3 in total

1.  Hysterosalpingogram: an essential examination following Essure hysteroscopic sterilisation.

Authors:  V Shah; N Panay; R Williamson; A Hemingway
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

2.  Contraception in patients with heart failure.

Authors:  Tara Sedlak; C Noel Bairey Merz; Chrisandra Shufelt; Kimberly D Gregory; Michele A Hamilton
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

3.  Efficacy, safety, and patient acceptability of the Essure™ procedure.

Authors:  Collette R Lessard; Matthew R Hopkins
Journal:  Patient Prefer Adherence       Date:  2011-04-28       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.